Transducin and melanopsin independent phototransduction in postnatal retinal development

NIH RePORTER · NIH · R01 · $338,765 · view on reporter.nih.gov ↗

Abstract

Genetic ablations of rod and cone transducin alpha subunits in the so-called KK mice do not silent the outer retina as we have found that inner retinal neurons still robustly respond to light. This surprised transducin-independent light sensitivity does not depend on melanopsin signaling in intrinsically photosensitive retinal ganglion cells. This so-named “transducin- and melanopsin-independent phototransduction (TMIP)” embodied in the 3K mice apparently works through an unknown and potentially novel signaling mechanism in retina. We have shown that TMIP-generated light signal passes through retinal circuit and is capable of driving retinal ganglion cells to confer image-forming vision. We hypothesize that TMIP occurs in developing and mature rod and/or cone photoreceptors, mediated by visual pigment and trimeric G-proteins, and indispensable for normal postnatal retinal development. In Aim-1 we will study the cellular origin of TMIP to determining relative contributions of rod and/or cone as candidate venue where TMIP takes place. In Aim-2 we will test the involvement of known visual pigments in TMIP, as well as trimeric G-proteins and other candidate signaling molecules/pathways. Aim-3 is to fully characterize TMIP’s role in light-dependent postnatal retinal development at times when transducin-dependent conventional phototransduction is yet to emerge. This application contains novel findings, conceptual, material and methodological innovations. Significance lies in the advancement of the phototransduction and retinal development fields, with clinical relevance in explaining mysteries concerning incomplete human achromatopsia involving Gnat2 and Cnga3 mutations.

Key facts

NIH application ID
10918303
Project number
5R01EY032898-04
Recipient
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
Principal Investigator
Ching-Kang Jason Chen
Activity code
R01
Funding institute
NIH
Fiscal year
2024
Award amount
$338,765
Award type
5
Project period
2022-09-01 → 2027-06-30